Ona Therapeutics
SpainEntry
2026
Hold
New
Status
Active
Who owns Ona Therapeutics?
Ona Therapeutics is currently owned by Merieux Equity Partners through Mérieux Innovation 2 (2024 vintage), since 2026. Across its history, Ona Therapeutics has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-06-10
Most recent investor
Merieux Equity PartnersMérieux Innovation 2 · 2024 · VC
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Asabys Partners, Alta Life Sciences, Ysios Capital Partners and Merieux Equity Partners since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-held by Asabys Partners, Alta Life Sciences, Ysios Capital Partners and Merieux Equity Partners since 2019.
Co-invest · 3 holders · 2019 · present
Asabys PartnersActive
2019 · present(7yr) · Sabadell Asabys Health Innovation Investments · 2019 · Life Sciences VC
Ysios Capital PartnersActive
2020 · present(6yr) · Ysios BioFund III · 2020 · Life Sciences VC
Alta Life SciencesActive
2020 · present(6yr) · Alta Life Sciences Spain I FCR · 2016 · Life Sciences VC
Merieux Equity PartnersActive
2026 · present(<1yr) · Mérieux Innovation 2 · 2024 · VC
More from Mérieux Innovation 2
Other portfolio companies in the same fund.
United KingdomMore PE-backed in Healthcare
Comparable healthcare deals from other GPs.
USTrack Ona Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Ona Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue